Shots:The EC has approved Amvuttra (vutrisiran) to treat ATTR-CM adults  as an additional indication, based on the global P-III (HELIOS-B) study assessing it vs PBO in ATTR-CM ptsThe study met all ten 1 & 2EPs across both overall & monotx. arms, showing improved outcomes of mortality, CV events & functional capacity with 6min. walk…